Filter
5401
Filtered Results: 5401
Text search:
drug
access
Featured
Recommendations
469
New Publications
1437
Language
Document type
No document type
3364
Studies & Reports
824
Guidelines
635
Manuals
220
Strategic & Response Plan
157
Fact sheets
78
Training Material
60
Situation Updates
27
Infographics
17
Resource Platforms
9
Brochures
5
Online Courses
3
App
2
Countries / Regions
India
301
Global
170
Kenya
166
South Africa
140
Uganda
126
Ethiopia
122
Western and Central Europe
121
Nigeria
113
Nepal
93
Tanzania
90
Liberia
88
Sierra Leone
87
Malawi
86
Africa
81
Zambia
80
Myanmar / Burma
77
Latin America and the Carribbean
69
Bangladesh
69
Ghana
66
Rwanda
66
Eastern Europe
65
Ukraine
59
Philippines
47
Namibia
46
Zimbabwe
45
Asia
43
Cambodia
37
Lesotho
36
South–East Asia Region
35
Russia
33
Syria
29
Congo, Democratic Republic of
27
Senegal
26
Botswana
26
Indonesia
26
Mozambique
24
Burkina Faso
21
Colombia
19
Middle East and North Africa
19
East and Southern Africa
19
Brazil
19
South Sudan
19
Eswatini/ Swaziland
19
West and Central Africa
17
Cameroon
16
Tajikistan
14
Haiti
14
Albania
13
USA
13
Venezuela
13
Eastern Europe and Central Asia
13
Germany
12
Thailand
11
Guinea
11
Argentina
11
Vietnam
10
Georgia
10
Pakistan
10
Benin
9
Afghanistan
9
Moldova
9
China
8
Peru
8
Sudan
8
Yemen
8
Laos
7
Armenia
7
Paraguay
7
North Macedonia
6
Mexico
6
El Salvador
6
Western Pacific Region
6
Chile
5
Jordan
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
Turkey
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Bolivia
4
Mali
4
Libya
4
Somalia
4
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
North America
3
Spain
3
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Palestine
3
Angola
3
Bhutan
3
Madagascar
3
Serbia
2
Kazakhstan
2
Canada
2
Fiji
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Gabon
2
Uruguay
2
France
2
Portugal
2
Belarus
2
Romania
2
Poland
2
Honduras
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Malaysia
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Greece
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2063
Clinical Guidelines
461
Public Health
260
Women & Child Health
211
Key Resources
107
Capacity Building
80
Pharmacy & Technologies
57
Annual Report MEDBOX
1
Toolboxes
HIV
707
TB
539
Mental Health
530
AMR
268
COVID-19
234
Pharmacy
161
NTDs
161
NCDs
106
Caregiver
103
Rapid Response
84
Ebola
81
Planetary Health
73
Refugee
71
Conflict
65
Disability
62
Global Health Education
57
Health Financing Toolbox
37
Natural Hazards
19
Polio
19
Cholera
18
Social Ethics
16
Zika
16
Specific Hazards
14
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
For humanitarian organisations to respond effectively to complex crises, they require access to up-to-date evidence-based guidance. The COVID-19 crisis has highlighted the importance of updating global guidance to context-specific and evolving needs in humanitarian settings. Our study aimed to under...
Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such
communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen...
The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The BBV/STI Glossary is a resource for interpreters, translators and others who work in a health setting. It offers an extensive list of English terms related to sexual health and blood-borne viruses (such as hepatitis), with easy to understand definitions.
Accessed 13th of November 2015.
Trastornos por consumo de sustancias
Capítulo G.1
Manual de Salud Mental Infantil y Adolescente de la IACAPAP
Accessed: 14.03.2019
Руководство по инвестициям Глобального фонда для стран Восточной Европы и Центральной Азии. В ходе разработки Руководства Глобальный фонд стремился учесть мнени...
